Immediately after childbirth, the uterus is still enlarged, and inserting an IUS at that time can increase the risk of expulsion or perforation. Because it is a local intrauterine system, the amount of levonorgestrel circulating in the bloodstream is significantly lower than what is found in systemic hormonal contraceptives like birth control pills or injections.
Talking to Your Healthcare Provider About Kyleena and Breastfeeding
The recommended window for immediate postpartum insertion is typically within 10 minutes of delivering the placenta. Current research and clinical guidelines do not indicate any negative long-term effects on infant growth, development, or health due to exposure through breastfeeding.
This localized action is the foundation for its generally favorable safety profile during lactation, as less hormone enters the maternal circulation and, consequently, less is available to pass into breast milk. Estrogen, a hormone found in many combined contraceptives, is well-documented to suppress lactation, particularly in the early weeks postpartum.
Discussing Kyleena with Your Healthcare Provider While Breastfeeding
The hormone it releases, levonorgestrel, is a progestin, which is a synthetic form of the natural hormone progesterone. This compatibility stems from the fact that progestin does not significantly affect the hormonal pathways responsible for initiating and maintaining a robust milk supply.
More About Kyleena and breastfeeding
Looking at Kyleena and breastfeeding from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Kyleena and breastfeeding can make the topic easier to follow by connecting earlier points with a few simple takeaways.
